Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule motor activity	KIF26A KIF28P KIF2A KIF2C KIF23 DNAH7	8.71e-05	70	207	6	GO:0003777
GeneOntologyMolecularFunction	protein tyrosine phosphatase activity	PALD1 TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	9.93e-05	103	207	7	GO:0004725
GeneOntologyMolecularFunction	cell adhesion molecule binding	OBSCN SIRPB1 PTN KIRREL3 BMPR2 FBN1 PTPRD PTPRM AHNAK DSC2 LAMA5 LRRC4C PAICS THBS4 PAK2 CTNNA2 SLC14A2	1.77e-04	599	207	17	GO:0050839
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO7A KIF26A KIF28P KIF2A KIF2C KIF23 DNAH7	2.32e-04	118	207	7	GO:0003774
GeneOntologyMolecularFunction	nitrate reductase activity	MTARC2 MTARC1	3.19e-04	3	207	2	GO:0008940
GeneOntologyMolecularFunction	uracil transmembrane transporter activity	SLC29A3 SLC29A1	3.19e-04	3	207	2	GO:0015210
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBN1 FBN2 AHNAK	3.67e-04	14	207	3	GO:0097493
GeneOntologyMolecularFunction	cytidine transmembrane transporter activity	SLC29A3 SLC29A1	6.33e-04	4	207	2	GO:0015212
GeneOntologyMolecularFunction	guanine transmembrane transporter activity	SLC29A3 SLC29A1	6.33e-04	4	207	2	GO:0015208
Domain	IGc2	VSIG4 OBSCN SIRPB2 DCC KIRREL3 FCRL1 PTPRD PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3	1.17e-11	235	203	19	SM00408
Domain	Ig_sub2	VSIG4 OBSCN SIRPB2 DCC KIRREL3 FCRL1 PTPRD PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3	1.17e-11	235	203	19	IPR003598
Domain	Ig_I-set	VSIG4 OBSCN DCC KIRREL3 FCRL1 PTPRD PTPRS PXDNL SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3	2.98e-11	190	203	17	IPR013098
Domain	I-set	VSIG4 OBSCN DCC KIRREL3 FCRL1 PTPRD PTPRS PXDNL SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3	2.98e-11	190	203	17	PF07679
Domain	IG	IL11RA VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3 CD79B	2.18e-10	421	203	23	SM00409
Domain	Ig_sub	IL11RA VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3 CD79B	2.18e-10	421	203	23	IPR003599
Domain	-	IL11RA HLA-DQA1 VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 PKHD1L1 IGDCC4 CD22 PLXNC1 CNTN3 CD79B TGM7 IL5RA	7.94e-10	663	203	28	2.60.40.10
Domain	IG_LIKE	IL11RA HLA-DQA1 VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3 CD79B	8.18e-10	491	203	24	PS50835
Domain	Ig-like_dom	IL11RA HLA-DQA1 VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CD22 CNTN3 CD79B	1.32e-09	503	203	24	IPR007110
Domain	Ig-like_fold	IL11RA HLA-DQA1 VSIG4 OBSCN SIRPB2 SIRPB1 DCC KIRREL3 FCRL1 PTPRD PTPRM PTPRS PXDNL KIT SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 PKHD1L1 IGDCC4 CD22 PLXNC1 CNTN3 CD79B TGM7 IL5RA	3.20e-09	706	203	28	IPR013783
Domain	ig	IL11RA VSIG4 OBSCN PTPRD PTPRM PTPRS KIT HSPG2 SDK2 ADAMTSL3 CD22 CNTN3	1.17e-06	190	203	12	PF00047
Domain	Immunoglobulin	IL11RA VSIG4 OBSCN PTPRD PTPRM PTPRS KIT HSPG2 SDK2 ADAMTSL3 CD22 CNTN3	1.17e-06	190	203	12	IPR013151
Domain	fn3	IL11RA OBSCN DCC PTPRD PTPRM PTPRS SDK1 SDK2 IGDCC4 CNTN3	1.14e-05	162	203	10	PF00041
Domain	FN3	IL11RA OBSCN DCC PTPRD PTPRM PTPRS SDK1 SDK2 IGDCC4 CNTN3 IL5RA	1.18e-05	199	203	11	PS50853
Domain	FN3_dom	IL11RA OBSCN DCC PTPRD PTPRM PTPRS SDK1 SDK2 IGDCC4 CNTN3 IL5RA	1.87e-05	209	203	11	IPR003961
Domain	FN3	IL11RA OBSCN DCC PTPRD PTPRM PTPRS SDK1 SDK2 IGDCC4 CNTN3	3.58e-05	185	203	10	SM00060
Domain	-	PALD1 TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	6.48e-05	92	203	7	3.90.190.10
Domain	LAMININ_IVA	HSPG2 LAMA2 LAMA5	6.81e-05	8	203	3	PS51115
Domain	Laminin_B	HSPG2 LAMA2 LAMA5	6.81e-05	8	203	3	PF00052
Domain	LamB	HSPG2 LAMA2 LAMA5	6.81e-05	8	203	3	SM00281
Domain	Laminin_IV	HSPG2 LAMA2 LAMA5	6.81e-05	8	203	3	IPR000034
Domain	SRCR	CD163 CD163L1 LOXL4 LOXL3	7.01e-05	21	203	4	PF00530
Domain	Prot-tyrosine_phosphatase-like	PALD1 TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	1.03e-04	99	203	7	IPR029021
Domain	Tyr_Pase_AS	TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	1.42e-04	73	203	6	IPR016130
Domain	-	CD163 CD163L1 LOXL4 LOXL3	1.43e-04	25	203	4	3.10.250.10
Domain	SR	CD163 CD163L1 LOXL4 LOXL3	1.43e-04	25	203	4	SM00202
Domain	SRCR-like_dom	CD163 CD163L1 LOXL4 LOXL3	1.68e-04	26	203	4	IPR017448
Domain	SRCR_1	CD163 CD163L1 LOXL4 LOXL3	1.68e-04	26	203	4	PS00420
Domain	SRCR_2	CD163 CD163L1 LOXL4 LOXL3	1.68e-04	26	203	4	PS50287
Domain	SRCR	CD163 CD163L1 LOXL4 LOXL3	1.95e-04	27	203	4	IPR001190
Domain	Ig_V-set	VSIG4 OBSCN SIRPB2 SIRPB1 KIRREL3 HSPG2 LRRC4C CNTN3 CD79B	3.37e-04	199	203	9	IPR013106
Domain	TYR_PHOSPHATASE_1	TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	3.50e-04	86	203	6	PS00383
Domain	MOSC	MTARC2 MTARC1	3.50e-04	3	203	2	PF03473
Domain	MOSC_N	MTARC2 MTARC1	3.50e-04	3	203	2	PF03476
Domain	MOSC	MTARC2 MTARC1	3.50e-04	3	203	2	PS51340
Domain	MOSC_N	MTARC2 MTARC1	3.50e-04	3	203	2	IPR005303
Domain	MoCF_Sase_C	MTARC2 MTARC1	3.50e-04	3	203	2	IPR005302
Domain	FBN	FBN1 FBN2	3.50e-04	3	203	2	IPR011398
Domain	TYR_PHOSPHATASE_dom	TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	3.72e-04	87	203	6	IPR000387
Domain	TYR_PHOSPHATASE_2	TPTE PTPRD PTPRM PTPRS TPTE2 PTPN5	3.72e-04	87	203	6	PS50056
Domain	Laminin_G	HSPG2 FAT4 LAMA2 LAMA5 THBS4	4.15e-04	58	203	5	IPR001791
Domain	PTPc_motif	PALD1 PTPRD PTPRM PTPRS PTPN5	4.49e-04	59	203	5	SM00404
Domain	Tyr_Pase_cat	PALD1 PTPRD PTPRM PTPRS PTPN5	4.49e-04	59	203	5	IPR003595
Domain	PTPc	PTPRD PTPRM PTPRS PTPN5	6.08e-04	36	203	4	SM00194
Domain	Nucleoside_tran	SLC29A3 SLC29A1	6.95e-04	4	203	2	PF01733
Domain	Eqnu_transpt	SLC29A3 SLC29A1	6.95e-04	4	203	2	IPR002259
Domain	LAM_G_DOMAIN	HSPG2 FAT4 LAMA2 LAMA5	7.49e-04	38	203	4	PS50025
Domain	TYR_PHOSPHATASE_PTP	PTPRD PTPRM PTPRS PTPN5	8.27e-04	39	203	4	PS50055
Domain	Laminin_G_2	HSPG2 FAT4 LAMA2 LAMA5	9.12e-04	40	203	4	PF02210
Domain	PTPase_domain	PTPRD PTPRM PTPRS PTPN5	1.00e-03	41	203	4	IPR000242
Domain	Y_phosphatase	PTPRD PTPRM PTPRS PTPN5	1.00e-03	41	203	4	PF00102
Domain	EGF	FBN1 FBN2 PLAU HSPG2 FAT4 LAMA2 LAMA5 ADAM32 THBS4	1.11e-03	235	203	9	SM00181
Domain	Lysyl_oxidase	LOXL4 LOXL3	1.15e-03	5	203	2	IPR001695
Domain	Laminin_domII	LAMA2 LAMA5	1.15e-03	5	203	2	IPR010307
Domain	LYSYL_OXIDASE	LOXL4 LOXL3	1.15e-03	5	203	2	PS00926
Domain	Sterol-sensing	HMGCR PTCH2	1.15e-03	5	203	2	PF12349
Domain	Lysyl_oxidase_CS	LOXL4 LOXL3	1.15e-03	5	203	2	IPR019828
Domain	Pyrv_Knase-like_insert_dom	MTARC2 MTARC1	1.15e-03	5	203	2	IPR011037
Domain	Laminin_aI	LAMA2 LAMA5	1.15e-03	5	203	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA5	1.15e-03	5	203	2	PF06008
Domain	Laminin_II	LAMA2 LAMA5	1.15e-03	5	203	2	PF06009
Domain	Lysyl_oxidase	LOXL4 LOXL3	1.15e-03	5	203	2	PF01186
Domain	Kinesin-like_fam	KIF26A KIF2A KIF2C KIF23	1.20e-03	43	203	4	IPR027640
Domain	-	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	3.40.850.10
Domain	Kinesin	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	PF00225
Domain	KISc	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	SM00129
Domain	KINESIN_MOTOR_1	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	PS00411
Domain	Kinesin_motor_dom	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	IPR001752
Domain	KINESIN_MOTOR_2	KIF26A KIF2A KIF2C KIF23	1.31e-03	44	203	4	PS50067
Domain	LamG	HSPG2 FAT4 LAMA2 LAMA5	1.31e-03	44	203	4	SM00282
Domain	IGv	VSIG4 OBSCN SIRPB1 HSPG2 LRRC4C	1.35e-03	75	203	5	SM00406
Domain	EGF-like_dom	FBN1 FBN2 PLAU HSPG2 FAT4 LAMA2 LAMA5 ADAM32 THBS4	1.65e-03	249	203	9	IPR000742
Domain	PAK_BD	PAK2 PAK3	1.71e-03	6	203	2	IPR033923
Domain	EGF_1	FBN1 FBN2 PLAU HSPG2 FAT4 LAMA2 LAMA5 ADAM32 THBS4	1.95e-03	255	203	9	PS00022
Domain	EGF-like_CS	FBN1 FBN2 PLAU HSPG2 FAT4 LAMA2 LAMA5 ADAM32 THBS4	2.28e-03	261	203	9	IPR013032
Domain	TB	FBN1 FBN2	2.38e-03	7	203	2	PF00683
Domain	EGF_2	FBN1 FBN2 PLAU HSPG2 FAT4 LAMA2 LAMA5 ADAM32 THBS4	2.52e-03	265	203	9	PS01186
Domain	Quinoprotein_ADH-like_supfam	WDR90 MTARC2 WDR7 WDR27	2.62e-03	53	203	4	IPR011047
Domain	-	KLHL28 KEAP1 KLHL5	3.05e-03	27	203	3	2.130.10.80
Domain	PTEN_C2	TPTE TPTE2	3.15e-03	8	203	2	PF10409
Domain	-	FBN1 FBN2	3.15e-03	8	203	2	3.90.290.10
Domain	PTEN_C2	TPTE TPTE2	3.15e-03	8	203	2	SM01326
Domain	C2_TENSIN	TPTE TPTE2	3.15e-03	8	203	2	PS51182
Domain	Tensin_lipid_phosphatase_dom	TPTE TPTE2	3.15e-03	8	203	2	IPR029023
Domain	Tensin_C2-dom	TPTE TPTE2	3.15e-03	8	203	2	IPR014020
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	OBSCN DCC KIRREL3 PTPRD PTPRM PTPRS LRRC4B LRRC4C IGDCC4 CD22 CNTN3	5.87e-09	162	214	11	25826454
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MPDZ DAPK1 SIRPB1 KEAP1 ARMCX4 TMEM132B PTPRD ARHGEF7 PTPRS PPP1R3F KIF2A PLCL1 KIF2C ARMC8 KIF23 WDR7 HECTD4 RANBP9 NETO1 PAK2 PAK3 CTNNA2	1.52e-07	963	214	22	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF609 KIF26A KEAP1 RGP1 ZZEF1 ADCY9 ST6GAL2 TECPR2 ARHGEF7 WDR90 SDK2 SZT2 HECTD4 LAMA5 INTS5 PDCD11	2.15e-07	529	214	16	14621295
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	TPTE DCAF8 ACOT7 PSMC2 MPDZ NCAPG2 FBN2 PTPRD PTPRM PTPRS KIF2C ARMC8 POLD1 TPTE2 RANBP9 YTHDC2 PAICS PTPN5 USP5 ATAD3A ATP5F1B	7.51e-07	974	214	21	28675297
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PALD1 HIP1 MYO7A KIF26A OBSCN ZZEF1 ADCY9 SLC8B1 PTPRS AHNAK RRP12 WDR90 GPC2 SNX11 HSPG2 SZT2 HECTD4 LAMA5 MFSD12 INTS5 MROH6 PDCD11	1.50e-06	1105	214	22	35748872
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	PALD1 PSMC2 MPDZ KEAP1 ADCY9 GCLM AHNAK BOD1L1 MED17 KIF2C HDAC6 DSC2 YTHDC2 PAICS ATAD3A PAK2 ATP5F1B	2.15e-06	708	214	17	39231216
Pubmed	Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.	PTPRD PTPRM PTPRS	2.28e-06	5	214	3	10777529
Pubmed	Development, composition, and structural arrangements of the ciliary zonule of the mouse.	FBN1 FBN2 HSPG2	2.28e-06	5	214	3	23493297
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	MYO7A PRPF6 KEAP1 RRP12 LOXL4 KIF2A KIF23 CALML3 POLD1 LAMA5 USP5 INTS5 ATAD3A ATP5F1B	2.81e-06	496	214	14	31343991
Pubmed	Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.	PTPRD PTPRM PTPRS	7.90e-06	7	214	3	12376545
Pubmed	Mediator CDK subunits are platforms for interactions with various chromatin regulatory complexes.	CDK8 CDK19 MED17	7.90e-06	7	214	3	22668559
Pubmed	Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.	CDK8 CDK19 MED17	1.26e-05	8	214	3	23749998
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	SDK1 SDK2 LRRC4C PLXNC1 CNTN3	1.73e-05	52	214	5	26633812
Pubmed	A genome-wide scan for breast cancer risk haplotypes among African American women.	ADAMTS16 ZMIZ1 PLXNC1	1.88e-05	9	214	3	23468962
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	KIRREL3 KIT SDK1 SDK2 NETO1 PLXNC1	2.18e-05	91	214	6	28558017
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	CDK8 ZNF609 CDK19 NCAPG2 BOD1L1 KIF2A MED17 KIF2C KIF23 POLD1 PRAME DNPEP	2.72e-05	453	214	12	29656893
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	SIRPB1 CD163 PTPRM PTPRS KIT HSPG2 DSC2 LAMA2 CNTN3	3.35e-05	257	214	9	16335952
Pubmed	PTPσ functions as a presynaptic receptor for the glypican-4/LRRTM4 complex and is essential for excitatory synaptic transmission.	PTPRD PTPRS GPC2	3.65e-05	11	214	3	25624497
Pubmed	Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference.	KIF2A KIF2C KIF23	3.65e-05	11	214	3	15843429
Pubmed	Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.	FBN1 FBN2	3.77e-05	2	214	2	12399449
Pubmed	Fibrillin-1 and fibrillin-2 are essential for formation of thick oxytalan fibers in human nonpigmented ciliary epithelial cells in vitro.	FBN1 FBN2	3.77e-05	2	214	2	21851253
Pubmed	New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis.	FBN1 FBN2	3.77e-05	2	214	2	30044367
Pubmed	Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils.	FBN1 FBN2	3.77e-05	2	214	2	21440062
Pubmed	MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.	FBN1 FBN2	3.77e-05	2	214	2	15131124
Pubmed	Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.	HIP1 KIT	3.77e-05	2	214	2	21697888
Pubmed	Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer.	CDK8 CDK19	3.77e-05	2	214	2	35181333
Pubmed	MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.	KIT MRGPRX2	3.77e-05	2	214	2	28987593
Pubmed	The expression pattern of laminin isoforms in Hirschsprung disease reveals a distal peripheral nerve differentiation.	LAMA2 LAMA5	3.77e-05	2	214	2	16226104
Pubmed	Regulatory functions of the Mediator kinases CDK8 and CDK19.	CDK8 CDK19	3.77e-05	2	214	2	30585107
Pubmed	A human homologue of Drosophila kelch associates with myosin-VIIa in specialized adhesion junctions.	MYO7A KEAP1	3.77e-05	2	214	2	11921171
Pubmed	Microfibril structure masks fibrillin-2 in postnatal tissues.	FBN1 FBN2	3.77e-05	2	214	2	20404337
Pubmed	The Chlamydomonas reinhardtii molybdenum cofactor enzyme crARC has a Zn-dependent activity and protein partners similar to those of its human homologue.	MTARC2 MTARC1	3.77e-05	2	214	2	21803866
Pubmed	MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol.	KIT MRGPRX2	3.77e-05	2	214	2	33524790
Pubmed	Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.	BMPR2 KIT	3.77e-05	2	214	2	16155937
Pubmed	Fibrillln mutations in Marfan syndrome and related phenotypes.	FBN1 FBN2	3.77e-05	2	214	2	8791520
Pubmed	Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments.	CLCN3 CLCN4	3.77e-05	2	214	2	28972156
Pubmed	HIV Transcription Is Independent of Mediator Kinases.	CDK8 CDK19	3.77e-05	2	214	2	31044597
Pubmed	Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18.	FBN1 FBN2	3.77e-05	2	214	2	8307578
Pubmed	Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy.	SDK1 SDK2	3.77e-05	2	214	2	15213259
Pubmed	CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis.	CD163 MRC1	3.77e-05	2	214	2	36183584
Pubmed	Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis.	CD163 CD163L1	3.77e-05	2	214	2	11124526
Pubmed	Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).	PSMC2 PLAU	3.77e-05	2	214	2	34244472
Pubmed	Isolation and characterization of a novel human gene, NIF3L1, and its mouse ortholog, Nif3l1, highly conserved from bacteria to mammals.	NIF3L1 KIT	3.77e-05	2	214	2	11124544
Pubmed	Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.	FBN1 FBN2	3.77e-05	2	214	2	7744963
Pubmed	MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including Molybdenum cofactor sulfurases.	MTARC2 MTARC1	3.77e-05	2	214	2	11886751
Pubmed	NGL-3 in the regulation of brain development, Akt/GSK3b signaling, long-term depression, and locomotive and cognitive behaviors.	LRRC4B LRRC4C	3.77e-05	2	214	2	31166939
Pubmed	Fibrillin microfibrils in bone physiology.	FBN1 FBN2	3.77e-05	2	214	2	26408953
Pubmed	Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration.	FBN1 FBN2	3.77e-05	2	214	2	18006876
Pubmed	Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians.	MTARC2 MTARC1	3.77e-05	2	214	2	24423752
Pubmed	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.	FBN1 FBN2	3.77e-05	2	214	2	24833718
Pubmed	Definition of the critical domains required for homophilic targeting of mouse sidekick molecules.	SDK1 SDK2	3.77e-05	2	214	2	15703275
Pubmed	Architecture of cell-cell adhesion mediated by sidekicks.	SDK1 SDK2	3.77e-05	2	214	2	30150416
Pubmed	Cyclin-Dependent Kinases 8 and 19 Regulate Host Cell Metabolism during Dengue Virus Serotype 2 Infection.	CDK8 CDK19	3.77e-05	2	214	2	32560467
Pubmed	CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes.	CD163 MRC1	3.77e-05	2	214	2	26352275
Pubmed	Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome.	FBN1 FBN2	3.77e-05	2	214	2	24265020
Pubmed	In vivo studies of mutant fibrillin-1 microfibrils.	FBN1 FBN2	3.77e-05	2	214	2	20529844
Pubmed	Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.	KIT MRGPRX2	3.77e-05	2	214	2	32044660
Pubmed	Aggresome formation is regulated by RanBPM through an interaction with HDAC6.	HDAC6 RANBP9	3.77e-05	2	214	2	24795145
Pubmed	Polarized PtdIns(4,5)P2 distribution mediated by a voltage-sensing phosphatase (VSP) regulates sperm motility.	TPTE TPTE2	3.77e-05	2	214	2	31776261
Pubmed	The role of mast cells in the development of skin fibrosis in tight-skin mutant mice.	FBN1 KIT	3.77e-05	2	214	2	7704626
Pubmed	Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.	FBN1 FBN2	3.77e-05	2	214	2	23133647
Pubmed	A novel regulator of p21-activated kinases.	ARHGEF7 PAK3	3.77e-05	2	214	2	9726964
Pubmed	Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.	KIT MRGPRX2	3.77e-05	2	214	2	31558225
Pubmed	The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity.	MPDZ KIT	3.77e-05	2	214	2	11018522
Pubmed	Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.	FBN1 FBN2	3.77e-05	2	214	2	1852206
Pubmed	[Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes].	CDK8 CDK19	3.77e-05	2	214	2	20408451
Pubmed	A standardized kinesin nomenclature.	KIF2C KIF23	3.77e-05	2	214	2	15479732
Pubmed	The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane.	MTARC2 MTARC1	3.77e-05	2	214	2	23086957
Pubmed	Microfibrils at basement membrane zones interact with perlecan via fibrillin-1.	FBN1 HSPG2	3.77e-05	2	214	2	15657057
Pubmed	Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration.	CLCN3 CLCN4	3.77e-05	2	214	2	32118314
Pubmed	Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences.	FBN1 FBN2	3.77e-05	2	214	2	12429739
Pubmed	Mediator kinase inhibition further activates super-enhancer-associated genes in AML.	CDK8 CDK19	3.77e-05	2	214	2	26416749
Pubmed	LAMA2 and LOXL4 are candidate FSGS genes.	LOXL4 LAMA2	3.77e-05	2	214	2	34565340
Pubmed	CDK8/19 Mediator kinases potentiate induction of transcription by NFκB.	CDK8 CDK19	3.77e-05	2	214	2	28855340
Pubmed	AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.	KIT HDAC6	3.77e-05	2	214	2	20233974
Pubmed	The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.	MTARC2 MTARC1	3.77e-05	2	214	2	25713076
Pubmed	Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development.	FBN1 FBN2	3.77e-05	2	214	2	12524050
Pubmed	Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.	CDK8 CDK19	3.77e-05	2	214	2	27678455
Pubmed	RPTP delta and the novel protein tyrosine phosphatase RPTP psi are expressed in restricted regions of the developing central nervous system.	PTPRD PTPRM	3.77e-05	2	214	2	8989520
Pubmed	Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.	FBN1 HSPG2	3.77e-05	2	214	2	23104139
Pubmed	Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.	FBN1 FBN2	3.77e-05	2	214	2	8120105
Pubmed	The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.	FBN1 FBN2	3.77e-05	2	214	2	35419902
Pubmed	CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI/SNF.	CDK8 CDK19	3.77e-05	2	214	2	36006697
Pubmed	Fibrillin assembly: dimer formation mediated by amino-terminal sequences.	FBN1 FBN2	3.77e-05	2	214	2	10504303
Pubmed	Efficient mitosis in human cells lacking poleward microtubule flux.	KIF2A KIF2C	3.77e-05	2	214	2	16243029
Pubmed	The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms.	CD163 MRC1	3.77e-05	2	214	2	31242338
Pubmed	CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins.	CDK8 CDK19	3.77e-05	2	214	2	37378433
Pubmed	Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity.	SLC29A3 SLC29A1	3.77e-05	2	214	2	12384580
Pubmed	Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC).	MTARC2 MTARC1	3.77e-05	2	214	2	21029045
Pubmed	Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse.	MTARC2 MTARC1	3.77e-05	2	214	2	38437227
Pubmed	The Fbn1 gene variant governs passive ascending aortic mechanics in the mgΔlpn mouse model of Marfan syndrome when superimposed to perlecan haploinsufficiency.	FBN1 HSPG2	3.77e-05	2	214	2	38545339
Pubmed	Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development.	FBN1 FBN2	3.77e-05	2	214	2	25524144
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	3.77e-05	2	214	2	9566880
Pubmed	Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.	TNFSF15 ZMIZ1	3.77e-05	2	214	2	28456797
Pubmed	Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina.	SDK1 SDK2	3.77e-05	2	214	2	12230981
Pubmed	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	FBN1 FBN2	3.77e-05	2	214	2	16407178
Pubmed	Is HSPG2 a modifier gene for Marfan syndrome?	FBN1 HSPG2	3.77e-05	2	214	2	32514132
Pubmed	B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.	FBN1 CD22	3.77e-05	2	214	2	15277237
Pubmed	N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.	FBN1 FBN2	3.77e-05	2	214	2	10359653
Pubmed	A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells.	TPTE TPTE2	3.77e-05	2	214	2	22164291
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN DCC KIRREL3 PTPRD PTPRM PTPRS PXDNL SDK1 HSPG2 SDK2 LRRC4B LRRC4C ADAMTSL3 IGDCC4 CNTN3	4.75e-12	161	149	15	593
GeneFamily	Immunoglobulin like domain containing	IL11RA VSIG4 DCC KIRREL3 FCRL1 PTPRM KIT SDK1 HSPG2 SDK2 ADAMTSL3 IGDCC4 CNTN3	7.33e-09	193	149	13	594
GeneFamily	Fibronectin type III domain containing	OBSCN DCC PTPRD PTPRM PTPRS SDK1 SDK2 IGDCC4 CNTN3	7.20e-06	160	149	9	555
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF26A KIF28P KIF2A KIF2C KIF23	3.71e-05	46	149	5	622
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	SIRPB1 CD163 FCRL1 KIT MRC1 CR1 TLR10 CD22 PLXNC1 CD79B FUT3 IL5RA	1.05e-04	394	149	12	471
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRM PTPRS	6.54e-04	21	149	3	813
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB2 SIRPB1	6.64e-04	5	149	2	747
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TPTE TPTE2	6.64e-04	5	149	2	902
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 TGFBR3	1.38e-03	7	149	2	570
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD163 CD163L1 MRC1	1.39e-03	27	149	3	1253
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TPTE TPTE2	1.83e-03	8	149	2	837
GeneFamily	Cyclins\|Mediator complex	CDK8 CDK19 MED17	2.50e-03	33	149	3	1061
GeneFamily	Synaptotagmin like tandem C2 proteins	TC2N SYTL3	2.91e-03	10	149	2	822
GeneFamily	Chloride voltage-gated channels	CLCN3 CLCN4	2.91e-03	10	149	2	302
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	CR1 FUT3 SLC29A1	3.47e-03	37	149	3	454
GeneFamily	Laminin subunits	LAMA2 LAMA5	4.22e-03	12	149	2	626
GeneFamily	Kelch like\|BTB domain containing	KLHL28 KEAP1 KLHL5	4.98e-03	42	149	3	617
GeneFamily	Solute carriers	SLC29A3 SLC26A1 SLC8B1 UCP3 SLC8A2 SLC22A16 SLC2A12 SLC14A2 SLC29A1	5.52e-03	395	149	9	752
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 SDK2 HECTD4 LAMA2 ZMIZ1 IGDCC4 CNTN3 ECHDC2 ZMAT1	1.52e-06	607	202	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	IL11RA SLC29A3 CDK19 PRPF6 LHX8 PGM5 ST6GAL2 BMPR2 FBN1 NRK BOD1L1 MTARC2 GPC2 FAT4 SDK2 LAMA2 ZMIZ1 IGDCC4 ABCB8 CNTN3 FGD6 ZMAT1	1.59e-05	834	202	22	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 BMPR2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 SDK2 SELENBP1 LAMA2 ZMIZ1 IGDCC4 CNTN3	1.61e-05	652	202	19	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	IL11RA SLC29A3 CDK19 LHX8 PGM5 BMPR2 FBN1 NRK MTARC2 GPC2 MRC1 SDK2 LAMA2 ZMIZ1 IGDCC4 CNTN3 ECHDC2 ZMAT1	1.69e-05	596	202	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 SDK2 HECTD4 LAMA2 ZMIZ1 IGDCC4 CNTN3 ZMAT1	1.71e-05	655	202	19	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 BMPR2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 SDK2 SELENBP1 LAMA2 ZMIZ1 IGDCC4 CNTN3 ZMAT1	2.36e-05	731	202	20	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 BMPR2 FBN1 MTARC2 GPC2 MRC1 FAT4 SDK2 SELENBP1 LAMA2 ZMIZ1 IGDCC4 ABCB8 CNTN3 ZMAT1	2.50e-05	734	202	20	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_100	MYO7A NRK HSD17B1 PLXNC1 PAK3	4.21e-05	41	202	5	gudmap_developingGonad_e18.5_testes_100_k3
CoexpressionAtlas	SC blastocyst_vs_SC-LF blastocyst-Confounder_removed-fold2.0_adjp0.05	PRSS16 TMEM132B PTN FBN2 TC2N KIT EFL1 DSC2 LRRC4B KLHL5	4.39e-05	216	202	10	PCBC_ratio_SC blastocyst_vs_SC-LF blastocyst_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 BMPR2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 LAMA2 ZMIZ1 IGDCC4 CNTN3 ZMAT1	4.48e-05	642	202	18	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	HLA-DQA1 SIRPB1 ST8SIA6 KIT CD22 PLXNC1	8.65e-05	76	202	6	GSM538248_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	DAPK1 PDCD4 PTN FBN1 FBN2 PTPRD NRK ADAMTS16 FAT4 SELENBP1 DSC2 SZT2 LRRC4C CBR3 IGDCC4 KLHL5 RNASEL PLXNC1 ZMAT1	8.85e-05	740	202	19	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500	DAPK1 PTN FBN1 FBN2 NRK FAT4 DSC2 SZT2 LRRC4C CBR3 KLHL5 RNASEL PLXNC1	9.33e-05	388	202	13	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	HLA-DQA1 SIRPB1 ST8SIA6 KIT CD22 PLXNC1	1.07e-04	79	202	6	GSM538265_100
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_100	MYO7A STAR NRK HSD17B1 PLXNC1 PAK3	1.41e-04	83	202	6	gudmap_developingGonad_e18.5_testes_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	KLHL28 MPDZ DAPK1 PDCD4 PTN FBN1 FBN2 PTPRD NRK FAT4 SELENBP1 DSC2 SZT2 LRRC4C CBR3 KLHL5 RNASEL PLXNC1 ZMAT1	1.83e-04	783	202	19	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_100	MYO7A NRK HSD17B1 PLXNC1	2.05e-04	31	202	4	gudmap_developingGonad_P2_testes_100_k1
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5	IL11RA SLC29A3 CDK19 LHX8 PGM5 ST6GAL2 BMPR2 MTARC2 GPC2 FAT4 SDK2 SELENBP1 LAMA2 ZMIZ1 IGDCC4 ABCB8 CNTN3 ZMAT1	2.09e-04	726	202	18	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	IL11RA MPDZ HSD11B1L PDCD4 PTN FBN1 PTPRD PPP1R3F PLAU LOXL3 HSD17B1 SDK2 HDAC6 SELENBP1 LAMA5 LRRC4B IGDCC4 PTPN5 TGFBR3 KLHL5 THBS4 CTNNA2 SLC2A12	2.43e-04	1075	202	23	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	IL11RA CDK19 LHX8 PGM5 ST6GAL2 FBN1 NRK MTARC2 GPC2 MRC1 FAT4 SDK2 LAMA2 ZMIZ1 IGDCC4 CNTN3 FGD6 ZMAT1	2.82e-04	744	202	18	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2	IL11RA CDK19 PGM5 FBN1 NRK MRC1 LAMA2	3.01e-04	134	202	7	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_200	MYO7A NRK HSD17B1 PLXNC1 PAK3	3.09e-04	62	202	5	gudmap_developingGonad_e16.5_testes_200_k5
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_200	MYO7A NRK HSD17B1 PLXNC1 PAK3	3.33e-04	63	202	5	gudmap_developingGonad_P2_testes_200_k4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL11RA PTN ST6GAL2 FBN1 PTPRD PXDNL AHNAK NRK ADAMTS16 ADAMTSL3 PTCH2	3.13e-09	197	213	11	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN DCC FBN2 PTPRD NRK ADAMTS16 SDK1 FAT4 LRRC4C PKHD1L1	2.14e-08	184	213	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN DCC FBN2 PTPRD NRK ADAMTS16 SDK1 FAT4 LRRC4C PKHD1L1	2.14e-08	184	213	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN DCC FBN2 PTPRD NRK ADAMTS16 SDK1 FAT4 LRRC4C PKHD1L1	2.14e-08	184	213	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19_Moderate-B_memory\|COVID-19_Moderate / disease group, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 LRRC4C CR1 TLR10 CD22 CD79B	2.46e-07	182	213	9	bbdbef62389ac062118cc0c7979686393399f2c8
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DQA1 MTARC2 LAMA5 PKHD1L1 TLR10 CD22 CD79B FGD6	2.82e-07	185	213	9	05e6eb78ead81268c1656e7ffe34f9cb7329b908
ToppCell	Multiple_Sclerosis-Lymphocyte-B-B_memory\|Multiple_Sclerosis / Disease, Lineage and Cell Type	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	3.23e-07	188	213	9	8da631b2c75441b7309f03e7d4c14f15f2367be6
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	3.23e-07	188	213	9	9256c5f45c97df209bb9c322c3b557d4f726a333
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	3.38e-07	189	213	9	ac0203f17b481d608587113ea2de0f383b29ed27
ToppCell	390C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA1 FCRL1 SDK2 CR1 PKHD1L1 TLR10 CD22 NETO1 CD79B	3.53e-07	190	213	9	f63c9474f23bb72f0bb1fc531342f0da04ed8b3e
ToppCell	390C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA1 FCRL1 SDK2 CR1 PKHD1L1 TLR10 CD22 NETO1 CD79B	3.53e-07	190	213	9	53bf211f0e8a44f5adb89c43b210a1e35120b6a8
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	3.69e-07	191	213	9	03f6da73e7b706252d2096507222229c4101a27b
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	3.69e-07	191	213	9	578b58782e816ecaeabfbc616ceb1dcd53ee428b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	4.03e-07	193	213	9	de0213f2105b814f38ffbfd004ea7603230eed68
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 FCRL1 CLCN4 MTARC2 PKHD1L1 TLR10 CD22 NETO1 CD79B	4.03e-07	193	213	9	c04ac5884be4245b75d211046f04d76ae0cfb998
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 FCRL1 CLCN4 MTARC2 PKHD1L1 TLR10 CD22 NETO1 CD79B	4.03e-07	193	213	9	6e6c5ae39ea880ba809019a7d39f50e4e02007ed
ToppCell	367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MYO7A HLA-DQA1 VSIG4 CD163 CD163L1 PLAU MRC1 DSC2 CR1	4.21e-07	194	213	9	e3688f4252aae5f849f025d7f453ff4c0c14590b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC FBN1 PTPRD PTPRS PXDNL MTARC2 SDK1 SDK2 IGDCC4	4.21e-07	194	213	9	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HIP1 DAPK1 IP6K1 FBN1 PTPRM SDK2 LAMA5 KLHL5 SLC29A1	4.39e-07	195	213	9	6a0460d949ccda7c9fe76870d3ee6c2f60677d61
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTN FBN1 SDK1 LAMA2 LRRC4B LRRC4C ADAMTSL3 TGFBR3 THBS4	4.59e-07	196	213	9	fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTN FBN1 SDK1 LAMA2 LRRC4B LRRC4C ADAMTSL3 TGFBR3 THBS4	4.59e-07	196	213	9	ee45e4de9d706ec87094e87f47d3e514539b8092
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IL11RA GLP2R FBN1 FBN2 AHNAK NRK ADAMTS16 ADAMTSL3 PTCH2	4.59e-07	196	213	9	eed9fe83ffc1f79493b70778962a671dd9f481e0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 HLA-DQA1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 PLXNC1	4.79e-07	197	213	9	6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7A VSIG4 SIRPB2 CD163 CD163L1 PLAU LOXL3 MRC1 CR1	4.99e-07	198	213	9	c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCell	Caecum-T_cell-cycling_gd_T\|Caecum / Region, Cell class and subclass	NCAPG2 TCAIM UCP3 PARPBP KIF2C KIF23 SELENBP1 ZMIZ1 CBR3	4.99e-07	198	213	9	5b719b67f8384863077070e1eb7e04a320e6dab4
ToppCell	Caecum-(1)_T_cell-(18)_cycling_gd_T\|Caecum / shred on region, Cell_type, and subtype	NCAPG2 TCAIM UCP3 PARPBP KIF2C KIF23 SELENBP1 ZMIZ1 CBR3	4.99e-07	198	213	9	64278d8831c81874937e76b561c53928dfc437c5
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	5.21e-07	199	213	9	025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-B-B_memory\|Multiple_Sclerosis / Disease, condition lineage and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	5.21e-07	199	213	9	ae2979c0d2711580863d3b751f6ff1e3abdfd90e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL11RA PTN FBN1 NRK ADAMTS16 FAT4 LAMA2 ADAMTSL3 THBS4	5.43e-07	200	213	9	76f3043cb88071256ff661885fe5a82a54f5b733
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL11RA PTN FBN1 NRK ADAMTS16 FAT4 LAMA2 ADAMTSL3 THBS4	5.43e-07	200	213	9	64d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7A VSIG4 SIRPB2 CD163 CD163L1 PLAU LOXL3 MRC1 CR1	5.43e-07	200	213	9	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DQA1 FCRL1 ST8SIA6 POLD1 CAPN11 CD22 CD79B IL5RA	9.69e-07	158	213	8	66c011e9de002224f70725dfe8e7871c8d304492
ToppCell	367C-Lymphocytic-B_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA1 FCRL1 TLR10 CD22 NETO1 CD79B TGM7 PRAME	1.54e-06	168	213	8	f4414d462d35abd00e3c1446302d7060f8a48d48
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DQA1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 CR1	1.54e-06	168	213	8	61a5435b27b01ff1a509ea463a6af220c5d2c9b3
ToppCell	367C-Lymphocytic-B_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA1 FCRL1 TLR10 CD22 NETO1 CD79B TGM7 PRAME	1.54e-06	168	213	8	1943ae24ff90218b8c2c10b4102b5007ae35fc85
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DQA1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 CR1	1.54e-06	168	213	8	26fce414439ccd204e3acb41f2b4f75072df5a26
ToppCell	3'_v3-blood-Lymphocytic_B-Naive_B_cells\|blood / Manually curated celltypes from each tissue	HLA-DQA1 DCC FCRL1 MTARC2 PKHD1L1 CD22 NETO1 CD79B	1.83e-06	172	213	8	f16f90d17feac1ee52fd513907b28456865fd31d
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS16 OBSCN DCC CD163L1 PKHD1L1 TACSTD2	1.88e-06	77	213	6	a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LYPLAL1 HLA-DQA1 PXDNL TLR10 ASB13 CD22 CD79B FGD6	2.00e-06	174	213	8	fde40c5d51f5380088360dc5a583eb04e518deb6
ToppCell	Control-B_cells-B_cells\|Control / group, cell type (main and fine annotations)	HLA-DQA1 FCRL1 SDK2 CR1 TLR10 CD22 NETO1 CD79B	2.18e-06	176	213	8	d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCell	severe-B_memory\|World / disease stage, cell group and cell class	HLA-DQA1 FCRL1 MTARC2 LAMA5 CR1 TLR10 CD22 CD79B	2.18e-06	176	213	8	4e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4
ToppCell	COVID-19_Moderate-B_memory\|World / disease group, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 LRRC4C TLR10 CD22 CD79B	2.57e-06	180	213	8	2f37187b866edb56410c2334b72713f2248dc335
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|normal_Lung / Location, Cell class and cell subclass	HIP1 DAPK1 RGP1 KIF2C KIF23 TLR10 PLXNC1 TACSTD2	2.68e-06	181	213	8	b55dbcfae8c92d322071906831489830a22239b9
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DQA1 FCRL1 BOD1L1 SRSF7 TLR10 CD22 NETO1 CD79B	2.68e-06	181	213	8	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 DAPK1 SIRPB2 SIRPB1 CD163 CD163L1 MRC1 PLXNC1	2.79e-06	182	213	8	ea39b1b5db185b0cb11dfa2e01f3f972effbd770
ToppCell	Control-Lymphocyte-B-B_memory\|Control / Disease, Lineage and Cell Type	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	2.91e-06	183	213	8	491fa04a1d2caeeec6c6403c9a38b4a1257fc2bc
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC TMEM132B ST6GAL2 PTPRS LAMA2 LRRC4B ADAMTSL3 PAK3	2.91e-06	183	213	8	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 HLA-DQA1 SIRPB2 CD163 KIT MRC1 TLR10 SYTL3	2.91e-06	183	213	8	a97f052950429245c3231464271e1ba539863bba
ToppCell	3'_v3-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	HLA-DQA1 FCRL1 MTARC2 LRRC4C PKHD1L1 TLR10 CD22 CD79B	2.91e-06	183	213	8	e3a418b745d7f040adf47be9e1043b945cae47ed
ToppCell	Healthy/Control-B_memory\|World / Disease group and Cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.03e-06	184	213	8	9e1879d86b535ede9b47deb0752e291f987a5d5e
ToppCell	control-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.28e-06	186	213	8	93066e9a043036dbdadcbcc04fa6a7be7a562596
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL11RA PGM5 FBN1 FBN2 PTPRD NRK ADAMTSL3 PAK3	3.28e-06	186	213	8	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	BL-critical-LOC-Lymphoid-B_cell\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HLA-DQA1 FCRL1 MTARC2 LRRC4C PKHD1L1 TLR10 CD22 CD79B	3.28e-06	186	213	8	27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8
ToppCell	3'_v3-blood-Lymphocytic_B\|blood / Manually curated celltypes from each tissue	HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 NETO1 CD79B	3.28e-06	186	213	8	5624b1fc7eab9f505588fcc86a24d14f8bcbfef7
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.41e-06	187	213	8	ea56cfca919a09db852b7ee5e42323f822962465
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.41e-06	187	213	8	43f81863063509337bd56a67010c62fb51109bd5
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 FCRL1 CLCN4 SDK2 TLR10 CD22 NETO1 CD79B	3.41e-06	187	213	8	d01926be1c8846a25fb6706e26b56b808b69f8f0
ToppCell	Healthy_donor-B_memory\|World / disease group, cell group and cell class (v2)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.41e-06	187	213	8	4f68e3243071a4549c80aff8bff32c6ad892ee7f
ToppCell	Control-Lymphoid_B-B_memory\|Control / Disease group, lineage and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.55e-06	188	213	8	ba4245de3bee29118abab57c4fce60b2007a189c
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.55e-06	188	213	8	b6ae707b033a17c75ca81f9194631ead1b63d170
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.55e-06	188	213	8	cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9
ToppCell	Healthy/Control-B_memory\|Healthy/Control / Disease group and Cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.55e-06	188	213	8	3aff07f77b2b15e7a30e47b30115178abe64474e
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PTN FBN1 SDK1 LAMA2 ADAMTSL3 TGFBR3 THBS4	3.69e-06	189	213	8	6b3b42d758b63a0df62310c34fa3bde421c1afd7
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PTN FBN1 SDK1 LAMA2 ADAMTSL3 TGFBR3 THBS4	3.69e-06	189	213	8	344b23d3c47d0665dda1cd4856a5e72f1c28cfb3
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO7A HLA-DQA1 VSIG4 SIRPB1 CD163 CD163L1 MRC1 MFSD12	3.69e-06	189	213	8	b8cbfc47f3f40b6fccd15899d58c87d07b0001aa
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADCY9 FBN1 PTPRD PTPRS PXDNL MTARC2 SDK1 SDK2	3.69e-06	189	213	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	remission-B_memory\|remission / disease stage, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.69e-06	189	213	8	a7b434a5d2cc7c3952cb8f16d11219b691c6c2b6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PGM5 ST8SIA6 PTPRM PKHD1L1 PTPN5 TGFBR3 KLHL5	3.84e-06	190	213	8	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	HLA-DQA1 FCRL1 CLCN4 PKHD1L1 TLR10 CD22 NETO1 CD79B	3.84e-06	190	213	8	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26A PGM5 BMPR2 KIT HSPG2 CALHM5 TGFBR3 PLXNC1	3.84e-06	190	213	8	a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCell	Healthy_donor-B_memory\|Healthy_donor / disease group, cell group and cell class (v2)	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.84e-06	190	213	8	46104a521f00d399315deca86699cb261b2795d6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 CR1	3.84e-06	190	213	8	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26A PGM5 BMPR2 KIT HSPG2 CALHM5 TGFBR3 PLXNC1	3.84e-06	190	213	8	25525fee1da8a808034d9c916159fd0b6b26bce8
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 NETO1 CD79B	3.99e-06	191	213	8	a831e30f37aff329d83fac9bdb84f783075d5df6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 CR1	3.99e-06	191	213	8	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	B_cell_maturation-Memory_B_cell\|World / Lineage and Cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.99e-06	191	213	8	528c3dea44238233dc1aa8d6ba5c3a191d18d985
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC PGM5 PTPRS PXDNL PLCL1 SDK1 TGFBR3 PAK3	3.99e-06	191	213	8	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	COVID-19_Convalescent-Lymphoid_B-B_memory\|COVID-19_Convalescent / Disease group, lineage and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	3.99e-06	191	213	8	4a853cd2434b0f5b18e1f853c37515845046c88b
ToppCell	3'_v3-bone_marrow-Lymphocytic_B\|bone_marrow / Manually curated celltypes from each tissue	HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 NETO1 CD79B	4.15e-06	192	213	8	8a284b6e499f5a3c116d5551430f00ecad4a3681
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PALD1 PGM5 TC2N AHNAK MRC1 PKHD1L1 THBS4 PAK3	4.15e-06	192	213	8	b016e229300c183e14c0e2bba494bf49c7899112
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PALD1 PGM5 TC2N AHNAK MRC1 PKHD1L1 THBS4 PAK3	4.15e-06	192	213	8	ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GLP2R FBN1 ADAMTS16 FAT4 LAMA2 ADAMTSL3 IGDCC4 PAK3	4.15e-06	192	213	8	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	PALD1 HIP1 HLA-DQA1 MTARC2 TPTE2 CBR3 TACSTD2 SLC29A1	4.15e-06	192	213	8	f18da8db573e584c8b90df0814afcf020360108e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	4.15e-06	192	213	8	185dd150d3345cd29625052a46f3ed89f2a9a8f6
ToppCell	control-B_memory\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	4.15e-06	192	213	8	d6ef271b6c4f9b49323650f3f773abd61c1b13c3
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	GLP2R FBN1 NRK FAT4 LAMA2 ADAMTSL3 IGDCC4 PAK3	4.15e-06	192	213	8	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A ARMCX4 BMPR2 ZBTB39 KIT MRC1 HSPG2 PLXNC1	4.31e-06	193	213	8	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FBN1 PTPRD PTPRS SDK1 FAT4 SDK2 LAMA2 CNTN3	4.31e-06	193	213	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBN1 TC2N PTPRS SDK1 LAMA2 ADAMTSL3 TGFBR3 PAK3	4.31e-06	193	213	8	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	4.48e-06	194	213	8	9657aef9f11d02d2f0e5cd4b4d8ba23eb2750d92
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IL11RA GLP2R FBN1 NRK FAT4 ADAMTSL3 IGDCC4 PTCH2	4.48e-06	194	213	8	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PALD1 HLA-DQA1 VSIG4 CD163 MRC1 SRSF7 CR1 PLXNC1	4.48e-06	194	213	8	5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LYPLAL1 HLA-DQA1 FCRL1 CR1 TLR10 CD22 CD79B FGD6	4.48e-06	194	213	8	f0c113edb706d53792892115b67277a285219942
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	4.48e-06	194	213	8	40c7f9bd69a8e843b81972e25a67f591021415dd
ToppCell	Control-B_memory-3\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	LYPLAL1 HLA-DQA1 AHNAK MTARC2 CR1 CBR3 TLR10 FGD6	4.65e-06	195	213	8	135234f068da3e8db7213b53c09ed6d1d0cdc351
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DQA1 FCRL1 MTARC2 PKHD1L1 TLR10 CD22 CD79B	4.65e-06	195	213	8	a4a3dc54b88bcdd82966ee0d5f7be00f227f5457
ToppCell	Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate\|Bac-SEP / Disease, condition lineage and cell class	HLA-DQA1 MTARC2 KIT PKHD1L1 TLR10 CD22 NETO1 CD79B	4.83e-06	196	213	8	1611920211beb1a3691e3853e0314792a74279a0
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-DQA1 FCRL1 MTARC2 CR1 PKHD1L1 TLR10 CD22 CD79B	4.83e-06	196	213	8	c450cd6b799932f5cce8326d1079114abeb71e95
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 VSIG4 SIRPB2 CD163 CD163L1 LOXL3 MRC1 CR1	4.83e-06	196	213	8	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	(3)_Macrophage_MARCOneg\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYO7A HLA-DQA1 VSIG4 CD163 CD163L1 PLAU MRC1 DSC2	5.01e-06	197	213	8	b0ee2ce1179b60b4542559acb300a34295277dbc
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A	ZNF609 DCAF8 ACOT7 MPDZ PDCD4 FBN1 CLCN4 ARHGEF7 MTARC2 EFL1 NNT	2.33e-06	199	208	11	1808_UP
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	DCC ZZEF1 ST8SIA6 SLC22A16	2.10e-06	14	204	4	EFO_0006830, EFO_0006896
Disease	mastocytosis (is_marker_for)	KIT IL5RA	4.76e-05	2	204	2	DOID:350 (is_marker_for)
Disease	developmental and epileptic encephalopathy 87 (implicated_via_orthology)	CDK8 CDK19	4.76e-05	2	204	2	DOID:0112221 (implicated_via_orthology)
Disease	Alcohol Withdrawal Seizures	MPDZ SLC29A1	4.76e-05	2	204	2	C0586323
Disease	unipolar depression, bipolar disorder	CDK8 ACADS DCC TCAIM PXDNL PLCL1 FAT4	1.11e-04	156	204	7	EFO_0003761, MONDO_0004985
Disease	Agenesis of corpus callosum	DCC PAK3	1.42e-04	3	204	2	C0175754
Disease	Dent disease (implicated_via_orthology)	CLCN3 CLCN4	1.42e-04	3	204	2	DOID:0050699 (implicated_via_orthology)
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2	1.42e-04	3	204	2	DOID:65 (implicated_via_orthology)
Disease	mantle cell lymphoma (is_marker_for)	CD79B PRAME	1.42e-04	3	204	2	DOID:0050746 (is_marker_for)
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	2.83e-04	4	204	2	DOID:0060249 (is_implicated_in)
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	KIF26A CTNNA2	2.83e-04	4	204	2	DOID:0090131 (is_implicated_in)
Disease	polymyositis	HLA-DQA1 SLC26A1 SDK2	3.40e-04	20	204	3	EFO_0003063
Disease	Alzheimer disease, educational attainment	HLA-DQA1 IP6K1 DCC PTN KCNJ3 EFL1 CR1 IGDCC4	3.41e-04	247	204	8	EFO_0011015, MONDO_0004975
Disease	melanoma	MYO7A DCC TMEM132B CD163L1 KIT FAT4 HDAC6 PRAME	3.50e-04	248	204	8	C0025202
Disease	kallikrein-7 measurement	CD163 CD163L1	4.69e-04	5	204	2	EFO_0008195
Disease	chordin-like protein 1 measurement	ARHGEF7 PAK3	4.69e-04	5	204	2	EFO_0020257
Disease	autosomal recessive limb-girdle muscular dystrophy (is_implicated_in)	HMGCR LAMA2	4.69e-04	5	204	2	DOID:0110274 (is_implicated_in)
Disease	Familial Glucocorticoid Deficiency Type 1	STAR NNT	4.69e-04	5	204	2	C4049650
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	KIF26A LHX8 DCC TMEM132B BMPR2 KCNJ3 PARPBP SDK1 LAMA2 WDR27 LRRC4C THBS4 CNTN3 CTNNA2 SLC14A2	4.89e-04	801	204	15	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Adenocarcinoma of large intestine	CDK8 DCC NRK KIT PAK3	5.52e-04	96	204	5	C1319315
Disease	aspartate aminotransferase measurement	MYO7A HLA-DQA1 OBSCN KEAP1 CD163 PANK2 PTPRD CLCN4 ST8SIA6 LOXL4 MTARC1 MRC1 HECTD4 MFSD12 MROH6 CTNNA2	5.86e-04	904	204	16	EFO_0004736
Disease	smoking behavior	ACADS DCC TMEM132B KCNJ3 SDK1 LAMA2 LRRC4C CTNNA2 SLC14A2	6.51e-04	341	204	9	EFO_0004318
Disease	Pituitary Gland Adenoma	CDK8 OR2W3	7.01e-04	6	204	2	EFO_1000478
Disease	heart septal defect	WDR7 YTHDC2	7.01e-04	6	204	2	MONDO_0002078
Disease	L lactate dehydrogenase measurement	HLA-DQA1 CD163 CD163L1	7.53e-04	26	204	3	EFO_0004808
Disease	Endogenous Hyperinsulinism	CD163 FBN1 MRC1	7.53e-04	26	204	3	C1257963
Disease	Exogenous Hyperinsulinism	CD163 FBN1 MRC1	7.53e-04	26	204	3	C1257964
Disease	Compensatory Hyperinsulinemia	CD163 FBN1 MRC1	7.53e-04	26	204	3	C1257965
Disease	obesity (implicated_via_orthology)	NMUR1 SDK1 FAT4 SDK2 HDAC6 CAPN11 ATP5F1B	7.75e-04	215	204	7	DOID:9970 (implicated_via_orthology)
Disease	Hyperinsulinism	CD163 FBN1 MRC1	9.39e-04	28	204	3	C0020459
Disease	functional impairment measurement	ZZEF1 ADAMTS16	9.76e-04	7	204	2	EFO_0005412
Disease	osteopetrosis (implicated_via_orthology)	CLCN3 CLCN4	9.76e-04	7	204	2	DOID:13533 (implicated_via_orthology)
Disease	Huntington disease, disease progression measurement	PTDSS1 ST8SIA6 PTPRM	1.15e-03	30	204	3	EFO_0008336, MONDO_0007739
Disease	Ischemic stroke, von Willebrand factor measurement	KIRREL3 TC2N HECTD4	1.15e-03	30	204	3	EFO_0004629, HP_0002140
Disease	X-linked Adrenal Hypoplasia	STAR NNT	1.30e-03	8	204	2	C0342482
Disease	Schizophrenia	PRSS16 SIRPB1 DCC CD163 PANK2 KCNJ3 KIF2A DRD3 SELENBP1 RANBP9 LAMA2 ADAMTSL3 PTPN5 PAK2 CTNNA2	1.30e-03	883	204	15	C0036341
Disease	nephrotic syndrome	HLA-DQA1 PTPRD RRP12 TNFSF15	1.50e-03	71	204	4	EFO_0004255
Disease	mitral valve prolapse (is_implicated_in)	FBN1 PLAU	1.66e-03	9	204	2	DOID:988 (is_implicated_in)
Disease	signal-regulatory protein beta-1 measurement	SIRPB2 SIRPB1	1.66e-03	9	204	2	EFO_0802069
Disease	orthostatic hypotension	STAR CD163L1	1.66e-03	9	204	2	EFO_0005252
Disease	refractive error, self reported educational attainment	FBN1 LAMA2 SLC14A2	1.66e-03	34	204	3	EFO_0004784, MONDO_0004892
Disease	IGA Glomerulonephritis	VSIG4 CD163 PLAU	1.66e-03	34	204	3	C0017661
Disease	Sarcomatoid Renal Cell Carcinoma	DAPK1 KEAP1 AHNAK RNF139 PRAME	2.00e-03	128	204	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DAPK1 KEAP1 AHNAK RNF139 PRAME	2.00e-03	128	204	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DAPK1 KEAP1 AHNAK RNF139 PRAME	2.00e-03	128	204	5	C1266044
Disease	Papillary Renal Cell Carcinoma	DAPK1 KEAP1 AHNAK RNF139 PRAME	2.00e-03	128	204	5	C1306837
Disease	Renal Cell Carcinoma	DAPK1 KEAP1 AHNAK RNF139 PRAME	2.00e-03	128	204	5	C0007134
Disease	gestational age, fetal genotype effect measurement	CDK19 SLC22A16	2.06e-03	10	204	2	EFO_0005112, EFO_0007959
Disease	Internal Carotid Artery Diseases	CD163 PLAU	2.51e-03	11	204	2	C0750986
Disease	Arterial Diseases, Common Carotid	CD163 PLAU	2.51e-03	11	204	2	C0750987
Disease	Carotid Atherosclerosis	CD163 PLAU	2.51e-03	11	204	2	C0577631
Disease	endometrial carcinoma, endometriosis	PTPRD TLR10	2.51e-03	11	204	2	EFO_0001065, EFO_1001512
Disease	External Carotid Artery Diseases	CD163 PLAU	2.51e-03	11	204	2	C0600178
Disease	Carotid Artery Diseases	CD163 PLAU	2.51e-03	11	204	2	C0007273
Disease	alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement	CDK19 SLC22A16	2.51e-03	11	204	2	EFO_0004357, EFO_0006870, EFO_0006883
Disease	forced expiratory volume, body mass index	HLA-DQA1 HECTD4	2.51e-03	11	204	2	EFO_0004314, EFO_0004340
Disease	response to cisplatin, response to antineoplastic agent	HAO1 PTPN5	2.51e-03	11	204	2	GO_0072718, GO_0097327
Disease	factor VIII measurement	HLA-DQA1 KIRREL3 TC2N	2.66e-03	40	204	3	EFO_0004630
Disease	multiple system atrophy	FBN2 LOXL4 PKHD1L1	2.66e-03	40	204	3	EFO_1001050
Disease	risk-taking behaviour	KIF26A HLA-DQA1 CDK19 DCC TMEM132B KIRREL3 PTPRM KCNJ3 RRP12 PARPBP SDK1 LRRC4C CTNNA2	2.67e-03	764	204	13	EFO_0008579
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	ACADS RBKS DCC TCAIM PXDNL PLCL1	2.76e-03	200	204	6	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	response to antihypertensive drug	HLA-DQA1 HECTD4 RNASEL	2.86e-03	41	204	3	EFO_0005405
Disease	Dental enamel hypoplasia	PTPRD ZMIZ1	3.00e-03	12	204	2	EFO_1001304
Disease	diffuse large B-cell lymphoma (is_implicated_in)	CD22 CD79B	3.00e-03	12	204	2	DOID:0050745 (is_implicated_in)
Disease	male infertility (implicated_via_orthology)	ADAMTS16 KIT	3.53e-03	13	204	2	DOID:12336 (implicated_via_orthology)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DAPK1 KEAP1 AHNAK RNF139 PRAME	3.74e-03	148	204	5	C0279702
Disease	pulse pressure measurement	HIP1 LYPLAL1 FBN1 FBN2 PTPRD PXDNL LOXL4 SNX11 HSD17B1 WDR7 LAMA5 ADAMTSL3 TGFBR3 ASB13 PLXNC1 CTNNA2 FGD6 SLC14A2 NNT	3.79e-03	1392	204	19	EFO_0005763
Disease	triacylglycerol 54:4 measurement	PIGX SDK1 MTARC1	3.97e-03	46	204	3	EFO_0010422
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	GLP2R ST8SIA6	4.10e-03	14	204	2	EFO_0004307, EFO_0008464
Disease	cerebellum cortex volume change measurement	PTPRD PTPRM	4.10e-03	14	204	2	EFO_0021497
Disease	colorectal cancer, colorectal adenoma	HLA-DQA1 HAO1 PLCL1 LAMA5 ZMIZ1	4.19e-03	152	204	5	EFO_0005406, MONDO_0005575
Disease	C-reactive protein measurement	HIP1 ACADS HLA-DQA1 RBKS ZZEF1 ADCY9 PGM5 BMPR2 AHNAK SNX11 KIT YTHDC2 GPRC6A ZMIZ1 GTPBP1 TLR10 MROH6	4.44e-03	1206	204	17	EFO_0004458
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	KEAP1 PLAU PLCL1 TNFSF15 OR5B21 ZMIZ1 DNPEP	4.60e-03	295	204	7	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	Hypogonadotropic hypogonadism	SLC29A3 POLD1	4.71e-03	15	204	2	C0271623
Disease	Primary hypogonadism	SLC29A3 POLD1	4.71e-03	15	204	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	SLC29A3 POLD1	4.71e-03	15	204	2	C3489396
Disease	sitting height ratio	PTPRM ZMIZ1 ADAMTSL3	5.31e-03	51	204	3	EFO_0007118
Disease	Endometrioma	FBN1 HSD17B1 MED17 PLXNC1 TACSTD2	5.34e-03	161	204	5	C0269102
Disease	Endometriosis	FBN1 HSD17B1 MED17 PLXNC1 TACSTD2	5.34e-03	161	204	5	C0014175
Disease	developmental dysplasia of the hip	LOXL4 ADAMTSL3	5.35e-03	16	204	2	EFO_1000648
Disease	gastroparesis	HLA-DQA1 PXDNL	5.35e-03	16	204	2	EFO_1000948
Disease	Hypogonadism	SLC29A3 POLD1	5.35e-03	16	204	2	C0020619
Disease	myopia (is_implicated_in)	LOXL3 LAMA2	5.35e-03	16	204	2	DOID:11830 (is_implicated_in)
Disease	phospholipids in IDL measurement	HLA-DQA1 HMGCR MTARC1	5.61e-03	52	204	3	EFO_0022164
Disease	vital capacity	ACADS PRSS16 HLA-DQA1 DCC ZZEF1 PTPRD PLCL1 HSPG2 LAMA2 WDR27 ZMIZ1 ADAMTSL3 CD79B CTNNA2 SLC2A12 SLC14A2 NNT	5.64e-03	1236	204	17	EFO_0004312
Disease	partial epilepsy	ADCY9 PTPRD	6.04e-03	17	204	2	EFO_0004263
Disease	bacterial pathogen genotype measurement, pulmonary tuberculosis	HLA-DQA1 DNPEP	6.04e-03	17	204	2	EFO_0010271, EFO_1000049
Disease	DNA methylation	HIP1 RBKS DCC ZNF467 PTPRM PTPRS PXDNL FAT4 WDR7 WDR27 LRRC4C	6.21e-03	656	204	11	GO_0006306
Disease	androstenedione measurement, estrone measurement	PTPRD PTPRM	6.77e-03	18	204	2	EFO_0007970, EFO_0007972
Disease	Feeding difficulties	CDK8 ZMIZ1	6.77e-03	18	204	2	C0232466
Disease	glucose homeostasis measurement, acute insulin response measurement	PTPRM SDK2	6.77e-03	18	204	2	EFO_0006831, EFO_0006896
Disease	response to clozapine	KIRREL3 CTNNA2	6.77e-03	18	204	2	GO_0097338
Disease	von Willebrand factor measurement	KIRREL3 TC2N ADAM32	6.90e-03	56	204	3	EFO_0004629

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQVTFRGMTSECSEI	TNFSF15	151	O95150
KGCVITISGRMTFTS	ACOT7	286	O00154
CGMTTVLTLTGVSRL	BARGIN	631	Q6ZT62
RMALDILTAAEGGTC	ERVPABLB-1	381	P60509
CARDLSSGTMVDVPA	DAPK1	1091	P53355
GTGISMSACREIALL	CDK19	56	Q9BWU1
SIREMACTTGVLQTL	DNPEP	451	Q9ULA0
AMEEISRGCASTGVI	ACADS	101	P16219
RKCSEVARLTEGMSG	ATAD3A	561	Q9NVI7
MSGSSECVRLLIDVG	ASB13	126	Q8WXK3
AERVERLMCTGSQTF	EFL1	371	Q7Z2Z2
TATILSMDKDCLRTG	GTPBP1	521	O00178
TRSAVDMACSVLGVA	GCLM	106	P48507
RAGMAASLTVDSCSE	FAT4	4066	Q6V0I7
SMGTERDVTATNGCL	APCDD1L	386	Q8NCL9
VAEMLCTATAIQGRS	CFAP46	981	Q8IYW2
SGKTGTCRISMSEVD	AHNAK	561	Q09666
VLSVVGMKCTRVGDS	CLDN19	96	Q8N6F1
DSMVTLSTCSGLRGI	ADAM32	106	Q8TC27
FEISGSMIERILVSC	ARHGEF7	546	Q14155
AAACLGGVTRMTVSL	CLCN4	521	P51793
SDMELRLVGGSSRCA	CD163L1	686	Q9NR16
VERSSLMGCSIEVTS	CAPN11	266	Q9UMQ6
TMCVLGLRDRASAAE	HSD11B1L	206	Q7Z5J1
CGTELRVMGFSTLAQ	CD79B	136	P40259
MSELTETVVCALGLS	HLA-DQA1	211	P01909
LGMSSVTSLDVTLCD	DSC2	656	Q02487
TTASRSGAGEEAMIC	ARMCX4	1766	Q5H9R4
LSTCQGLSGMIRTEE	ADAMTS16	161	Q8TE57
STVRTIAMDGTEGLV	ATP5F1B	106	P06576
AGMACAAASLAVVVR	IGDCC4	411	Q8TDY8
MARSGIGSCAFATVE	RANBP9	711	Q96S59
CSTVANDVMLRTGLG	NETO1	251	Q8TDF5
CRASNGMEASITVTV	HSPG2	2311	P98160
SERTTLCGADSMLLA	PARPBP	26	Q9NWS1
ERRGSNVSLTLDMCT	PTPN5	241	P54829
TREGTRTGAECKQTM	PTN	66	P21246
FLCIGSSVMAASLVT	SLC2A12	346	Q8TD20
CLSGQGRTTTAMVVA	PALD1	661	Q9ULE6
SVRLTCMLSSGFSVG	IGLV5-52	36	A0A0A0MRZ9
VSLGQMARITCSGEA	IGLV3-16	31	A0A075B6K0
SIDLRDRQGCTMVVG	PGM5	51	Q15124
AAVVVVGSCMTDLVS	RBKS	16	Q9H477
VGSCMTDLVSLTSRL	RBKS	21	Q9H477
AGGSLTDVVTETCMD	PAK3	361	O75914
TMRGGNVLLDCSAES	DCC	51	P43146
MSSSCSGLSRVLVAV	IL11RA	1	Q14626
GTTECILLTVMAFDR	OR2H2	106	O95918
TTTMTAGVCALLATG	OR5B21	131	A6NL26
VMSGVRCTGTELSLD	LOXL3	486	P58215
RAQEVVMSGVRCSGT	LOXL4	486	Q96JB6
VMSGVRCSGTELALQ	LOXL4	491	Q96JB6
SRCILTTVDPDTGVM	MTARC1	271	Q5VT66
RMTTGSTLCDVGSLG	NMUR1	391	Q9HB89
TISSARVNDSGVFMC	KIT	276	P10721
MERIEGASVGRCAAS	NUDT14	1	O95848
ARLSLTVCGDSRMAA	GPC2	406	Q8N158
RECILTLVNTGIGMT	HSP90AB4P	56	Q58FF6
DALVECLVIGVGTMS	HMGCR	171	P04035
ACDLRVAASSAVMGL	ECHDC2	146	Q86YB7
VTVGMDSRCHIDLSG	KRT80	236	Q6KB66
STLAMCARDGQVRVA	DCAF8L2	286	P0C7V8
DAIGISQASMSRCVA	HARBI1	91	Q96MB7
REMTSKLLSDLCGTV	PDCD4	216	Q53EL6
MSVCLSGFLRETVGE	PLXNC1	1141	O60486
RMACVSTVAIEGTVF	OR2W3	186	Q7Z3T1
STLAMCARDGQVRVA	DCAF8	251	Q5TAQ9
ELATVRACQSLGTGM	HAO1	91	Q9UJM8
VHCAMGVSRSATLVL	DUSP13	136	Q9UII6
SAMSASVGDRVTITC	IGKV1D-17	31	A0A075B6S4
MSEECGRTTALAAGR	LHX8	11	Q68G74
RESLATAGCRTTMIA	KIF26A	686	Q9ULI4
ADAVRVITFTGCMGE	LAMA2	2291	P24043
FGSCSKTIEMLTGRI	KCNRG	126	Q8N5I3
TEGMAAELKCRASTS	LRRC4C	366	Q9HCJ2
MLFETLTCSSGTLRT	NLRP2	1001	Q9NX02
MSGVRAVRISIESAC	MED17	1	Q9NVC6
ATRALGEMLAVSGCV	MROH6	241	A6NGR9
VSAGCTADLLVGRAM	LAMA5	3111	O15230
EAFGETMTSVVSLCA	HECTD4	1246	Q9Y4D8
VASMSISRDAVGVCL	KLHL5	691	Q96PQ7
VERTRTATMLCAASG	PTPRS	146	Q13332
DTCTEVTVAMAATLR	GPRC6A	101	Q5T6X5
SSSSKVRMEAVGCTR	OBSCN	1391	Q5VST9
TGCTTFEEALEMASR	PANK2	426	Q9BZ23
SFIGENSRTCMIATI	KIF2A	516	O00139
LAGGSLTDVVTETCM	PAK2	326	Q13177
VLIGTSTTLECMATG	PXDNL	341	A1KZ92
STSEGCEAVMIGAVL	BOD1L1	2296	Q8NFC6
TECAVVLGSLAMGTE	ARMC8	81	Q8IUR7
MITSLGCEAVERASA	HAL	311	P42357
VQVRAAVSSMCREAG	IL5RA	306	Q01344
VTLEGRAGALCAMRS	HEATR5B	606	Q9P2D3
RGSSLSECSEGDVTM	GLP2R	526	O95838
TTRSCFAAAVLDGMI	KLHL28	421	Q9NXS3
CSSLGMVVIADLSTD	BRME1	331	Q0VDD7
ISGAALMADSSCTRD	CTNNA2	311	P26232
MTFNLIGESSIRCTS	CR1	1811	P17927
EGDRLVLICSVAMGT	FCRL1	126	Q96LA6
GLDGRVCVDTHMRST	FBN1	646	P35555
ECAMSGTRSSGLLEL	CALHM5	126	Q8N5C1
MARTVVLITGCSSGI	HSD17B1	1	P14061
TDGFGIDTCRSMVAV	CAPNS1	136	P04632
LEVASPATVSRCGMI	DNAH7	1736	Q8WXX0
DDCSLMGTLGEAVTI	DNAH7	2946	Q8WXX0
TCVISDFGLSMRLTG	BMPR2	346	Q13873
VNIASRMDTTGVECR	ADCY9	1191	O60503
VPVSEAECTAMGLRS	MTARC2	71	Q969Z3
MAAASGSVLQRCIVS	LYPLAL1	1	Q5VWZ2
MSSCSRVALVTGANR	CBR3	1	O75828
RLTCEISTRGTSAGM	FAM118B	316	Q9BPY3
STSATLGVRVCGMQV	IP6K1	251	Q92551
TAMNTIRSGAGVCVL	KEAP1	501	Q14145
VLGMGSSSIELCERE	KIRREL3	696	Q8IZU9
VIAASTMSVCSSDVG	KRTAP10-8	11	P60410
DSMALGCTTVIERGT	LINC01545	26	Q5VT33
GCITTRELGTVMRSL	CALML3	26	P27482
SISESMAACTRSLLG	HDAC6	786	Q9UBN7
TSTDGSRCIDQRTGM	FBN2	351	P35556
GKSSMSETTVGVVCR	CD163	851	Q86VB7
GTGISMSACREIALL	CDK8	56	P49336
VTDGMTAILRCEVSG	SDK1	491	Q7Z5N4
STVIDGMSVVLACET	SDK2	411	Q58EX2
TDSVMCRFGVSSVAE	POLD1	756	P28340
SFIGENSRTCMIATI	KIF2C	551	Q99661
GAGCATILVTSLAMT	MFSD12	376	Q6NUT3
CVVTSMVTNARVLGS	CNTN3	196	Q9P232
TELSCSQLGLMVTGE	KIF28P	786	B7ZC32
SDAIVREGDSVTMTC	CD22	251	P20273
GTGQSSCRRVALMIT	DRD3	141	P35462
TEGMAAELKCRTGTS	LRRC4B	376	Q9NT99
SGTFCAISIVCEMLR	PTPRM	1396	P28827
TCVAMSTLGVIEAIA	PTPRD	301	P23468
TRCSVAVEMRAGSQL	KIF23	931	Q02241
CVLLMAETVSGTRGS	SLC8B1	16	Q6J4K2
GITESCVLTAMAIDR	OR6K6	136	Q8NGW6
STVRGAHCIVVMADG	ABCB8	671	Q9NUT2
GTTECILLTVMAFDR	OR2H1	106	Q9GZK4
LECLRMGSSLVSIES	MRC1	1261	P22897
LCAAGSVTDVVRMTS	NRK	131	Q7Z2Y5
TCLGSVSALSAVMGV	NNT	806	Q13423
IISGCDSTLTVLGMS	RNF139	281	Q8WU17
VALSRCSEMVPGTAD	FUT3	76	P21217
GMTSVFICLRGTKED	RETSAT	386	Q6NUM9
TGAEIRSVCTEAGMF	PSMC2	381	P35998
GSLISIDSTCTEMGN	SYTL3	286	Q4VX76
EFMVQIGCASVSRSS	SZT2	2531	Q5T011
AVTIVCMVILSGAST	SLC29A3	166	Q9BZD2
EACVQGRSTMTVSDA	SNX11	136	Q9Y5W9
VCSLQGRMTLTGIVS	PLAU	381	P00749
CTIIFTDRSGMSAVG	TCAIM	266	Q8N3R3
TLSITNCRLSEGDVM	PRAME	326	P78395
EESRGSTISLMRTDC	TLR10	796	Q9BXR5
SRMDTTAVCTGGVTE	TMEM132B	6	Q14DG7
IGECSMSLRTLSTQE	TC2N	321	Q8N9U0
ELAGERLMAATSCRS	RGP1	196	Q92546
AGSVATCQAVMRAVI	PRPF6	516	O94906
RALGSGMAVDCSTLT	TACSTD2	56	P09758
TIVRSLAVGSGSMVC	SLC22A16	471	Q86VW1
LAVGSGSMVCRLASI	SLC22A16	476	Q86VW1
RSVGTAAVNMCLVAT	IMPA1	191	P29218
MGECLQRTGTSVVLT	PTCH2	491	Q9Y6C5
LDMSRSVSVTAAGQC	HIP1	206	O00291
GASTDCGDLVMTARR	RNASEL	296	Q05823
LSTGLMITSVAVELC	ST8SIA6	321	P61647
RGLRSCAVVMSAGAI	ST6GAL2	291	Q96JF0
CLASGEVMISSLGDV	SELENBP1	141	Q13228
ASCTLVAVMAEGSLL	INTS5	906	Q6P9B9
GLSMLSTVSTERCLS	MRGPRX2	116	Q96LB1
GRLCTLDESVSLATM	NIF3L1	251	Q9GZT8
SMSAELGVGCALRAV	PLPBP	6	O94903
VGAVTMVSCSILALT	RRP12	911	Q5JTH9
MICAIASGSELSESA	SLC29A1	191	Q99808
MVRSTGILGVCKITS	NCAPG2	391	Q86XI2
ACLGGVTRMTVSLVV	CLCN3	581	P51790
AGESATLRCAMTSLI	SIRPB1	46	O00241
CRVVVLMGSTSDLGH	PAICS	266	P22234
TIDTTMRGGRLGVFC	THBS4	911	P35443
GMLVRCVVSSLGITD	PDCD11	146	Q14690
KMGCRSVELDVSDGS	PLCL1	436	Q15111
AEGETLLLRCMVVGS	SIRPB2	51	Q5JXA9
GTDRTGTMVCAFLIA	TPTE	341	P56180
LTTRILAGCTTGAMA	UCP3	116	P55916
ERAQGMATLVFSRSC	TEX13D	481	A0A0J9YY54
DETRMASCGQGSVRL	WDR90	516	Q96KV7
CTVTVMGSASLDELL	WDR90	856	Q96KV7
TAARSDAGIRAMCSE	PIGX	31	Q8TBF5
DRIVTICGTSTEGMT	MPDZ	1911	O75970
GTAATCMLVSTEAGL	SLC26A1	476	Q9H2B4
KRRGSTCVLAGMATD	STAR	191	P49675
SVTAEMLTRCGIGKL	UBA5	86	Q9GZZ9
VICGSRVRVELSTGM	SRSF7	71	Q16629
MSLAVDEGTGFIRCT	FGD6	436	Q6ZV73
DEGTGFIRCTVSMSL	FGD6	441	Q6ZV73
MVRTRSVGVNTCDVA	ZNF609	281	O15014
EILSGARSVVATMGD	PPP1R3F	601	Q6ZSY5
TVRDGLEMSGCSERV	TECPR2	361	O15040
MESVSCSAAAVRTGD	TBCC	1	Q15814
LEGMGRISVTREGTC	PKHD1L1	966	Q86WI1
GETMRVAIFASGCSS	VSIG4	331	Q9Y279
CIAGLMRSITGRSVS	nan	121	A6NLC8
SETMCDVTIVVGSRS	ZBTB39	26	O15060
VECGKAFTRMSGLTR	ZNF264	486	O43296
CTNGVLLRTLMAGDS	YTHDC2	291	Q9H6S0
LARGSVAKVMSSLCT	ZZEF1	481	O43149
RTGTMVCALLIASEI	TPTE2	326	Q6XPS3
KLICRLSTTGAVDMT	WDR27	646	A2RRH5
VALSSCTMVLEGSGL	TGM7	636	Q96PF1
ISGCLGTIMSTLTAL	SLC14A2	616	Q15849
ALTSMVVLDAGCALR	PRR23C	56	Q6ZRP0
TGALDRCVMGITAVE	WDR7	591	Q9Y4E6
SRSLMSTAIGGSLEC	PRSS16	226	Q9NQE7
MASCVGSRTLSKDDV	PTDSS1	1	P48651
DCVTTIVSMGFSRDQ	USP5	726	P45974
QMSSSREERALGVCS	ZNF467	36	Q7Z7K2
ALMESFTVLSGCASR	TGFBR3	41	Q03167
QSLMGCLTVVSRVAA	ZMIZ1	51	Q9ULJ6
ESIGTLLDAIICRMS	TPRKB	156	Q9Y3C4
MESCSVTRLECSGAI	ZMAT1	1	Q5H9K5
GGIQRRSFVCVEESM	ADAMTSL3	436	P82987
GIVETTGMTCQARTS	KCNJ3	301	P48549
ECMGTVDVRVVRSSG	SLC8A2	536	Q9UPR5
LRGTCQRMAEAVLGT	MYO7A	701	Q13402